Company intelligence / Profile preview

Cleveland HeartLab

Cleveland, Ohio, United States

Ownership: Private
Employees: ~91
Development stage: Other

Overview

Cleveland HeartLab offers scientifically-proven inflammation and advanced biomarker testing that identifies cardiovascular risk beyond traditional cholesterol panels. A peer-reviewed study published in the Journal of Medical Economics demonstrated their inflammation testing could reduce average heart attack and stroke rates by approximately 10%, potentially averting $187 million in healthcare costs over five years.

Therapeutic areas: Cardiovascular
Modalities: Biomarker testing (non-pharmacological diagnostic)
Industry: Molecular Diagnostics

Partnerships

Cleveland Clinic (research and development collaboration)Quest Diagnostics (parent company post-acquisition)Procter & Gamble (TMAO biomarker development partnership)MDVIP (network of personalized care physicians)

Beyond the preview

Go deeper on Cleveland HeartLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cleveland HeartLab.

Explore the full profile